Full Text
CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX) IN PATIENTS WITH STAGE II COLON CANCER- MEDICAL AND ECONOMIC BENEFITS

Abstract

Authors

CA Uyl-de Groot MG Hanna MT Groot P Verboom HC Hoover JB Vermorken

Back to Volume 5, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×